Treatment of diabetes mellitus by diet alone versus oral hypoglycemics versus insulin and outcome after successful percutaneous coronary revascularization

David Hasdai, Robert A. Rizza, Diane E. Grill, Christopher G. Scott, Kirk N. Garratt, David Holmes

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Objective: To examine whether the outcomes of diabetic patients after successful percutaneous coronary revascularization are influenced by the modality of treatment for hyperglycemia at the time of percutaneous coronary revascularization. Design: Retrospective analysis of the Mayo Clinic PTCA Registry. Material and Methods: We examined whether the modality of treatment of diabetes mellitus (diet alone vs. oral hypoglycemics vs. insulin) impacted on the occurrence of death and death/myocardial infarction among diabetic patients after successful percutaneous coronary revascularization from January 1, 1995 through December 1998. Results: Of the 821 diabetic patients with known treatment status, 129 received diet alone, 370 oral agents, and 322 insulin. The clinical success rates of percutaneous coronary revascularization were similarly high among the groups (>90%). The adjusted risk of suffering either death or death/myocardial infarction after successful percutaneous coronary revascularization was greater for insulin-treated patients (vs. non-insulin): relative risk (95% confidence intervals) of 1.65 (0.99, 2.72) and 1.65 (1.20, 2.27), respectively. Patients treated with oral agents had lower risk of suffering death or death/myocardial infarction than insulin-treated patients (0.59 [0.36, 0.99] and 0.57 [0.38, 0.84], respectively), with a similar trend for patients on diet alone (0.96 [0.48, 1.99] and 0.65 [0.36, 1.16], respectively). Conclusions: Although the clinical success rates of PCR were similar for insulin- and non-insulin-treated diabetic patients, insulin-treated patients had worse long-term outcomes after successful percutaneous coronary revascularization.

Original languageEnglish (US)
Pages (from-to)138-143
Number of pages6
JournalHeartDrug
Volume1
Issue number3
DOIs
StatePublished - 2001

Fingerprint

Percutaneous Coronary Intervention
Hypoglycemic Agents
Diabetes Mellitus
Insulin
Diet
Therapeutics
Myocardial Infarction
Psychological Stress
Hyperglycemia
Registries
Confidence Intervals
Polymerase Chain Reaction

Keywords

  • Angioplasty
  • Coronary artery disease
  • Diabetes mellitus
  • Diet
  • Hypoglycemics
  • Insulin

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Cardiology and Cardiovascular Medicine

Cite this

Treatment of diabetes mellitus by diet alone versus oral hypoglycemics versus insulin and outcome after successful percutaneous coronary revascularization. / Hasdai, David; Rizza, Robert A.; Grill, Diane E.; Scott, Christopher G.; Garratt, Kirk N.; Holmes, David.

In: HeartDrug, Vol. 1, No. 3, 2001, p. 138-143.

Research output: Contribution to journalArticle

Hasdai, David ; Rizza, Robert A. ; Grill, Diane E. ; Scott, Christopher G. ; Garratt, Kirk N. ; Holmes, David. / Treatment of diabetes mellitus by diet alone versus oral hypoglycemics versus insulin and outcome after successful percutaneous coronary revascularization. In: HeartDrug. 2001 ; Vol. 1, No. 3. pp. 138-143.
@article{2d36f6e0dde349178f1d144bb3ce38df,
title = "Treatment of diabetes mellitus by diet alone versus oral hypoglycemics versus insulin and outcome after successful percutaneous coronary revascularization",
abstract = "Objective: To examine whether the outcomes of diabetic patients after successful percutaneous coronary revascularization are influenced by the modality of treatment for hyperglycemia at the time of percutaneous coronary revascularization. Design: Retrospective analysis of the Mayo Clinic PTCA Registry. Material and Methods: We examined whether the modality of treatment of diabetes mellitus (diet alone vs. oral hypoglycemics vs. insulin) impacted on the occurrence of death and death/myocardial infarction among diabetic patients after successful percutaneous coronary revascularization from January 1, 1995 through December 1998. Results: Of the 821 diabetic patients with known treatment status, 129 received diet alone, 370 oral agents, and 322 insulin. The clinical success rates of percutaneous coronary revascularization were similarly high among the groups (>90{\%}). The adjusted risk of suffering either death or death/myocardial infarction after successful percutaneous coronary revascularization was greater for insulin-treated patients (vs. non-insulin): relative risk (95{\%} confidence intervals) of 1.65 (0.99, 2.72) and 1.65 (1.20, 2.27), respectively. Patients treated with oral agents had lower risk of suffering death or death/myocardial infarction than insulin-treated patients (0.59 [0.36, 0.99] and 0.57 [0.38, 0.84], respectively), with a similar trend for patients on diet alone (0.96 [0.48, 1.99] and 0.65 [0.36, 1.16], respectively). Conclusions: Although the clinical success rates of PCR were similar for insulin- and non-insulin-treated diabetic patients, insulin-treated patients had worse long-term outcomes after successful percutaneous coronary revascularization.",
keywords = "Angioplasty, Coronary artery disease, Diabetes mellitus, Diet, Hypoglycemics, Insulin",
author = "David Hasdai and Rizza, {Robert A.} and Grill, {Diane E.} and Scott, {Christopher G.} and Garratt, {Kirk N.} and David Holmes",
year = "2001",
doi = "10.1159/000048950",
language = "English (US)",
volume = "1",
pages = "138--143",
journal = "HeartDrug",
issn = "1422-9528",
publisher = "S. Karger AG",
number = "3",

}

TY - JOUR

T1 - Treatment of diabetes mellitus by diet alone versus oral hypoglycemics versus insulin and outcome after successful percutaneous coronary revascularization

AU - Hasdai, David

AU - Rizza, Robert A.

AU - Grill, Diane E.

AU - Scott, Christopher G.

AU - Garratt, Kirk N.

AU - Holmes, David

PY - 2001

Y1 - 2001

N2 - Objective: To examine whether the outcomes of diabetic patients after successful percutaneous coronary revascularization are influenced by the modality of treatment for hyperglycemia at the time of percutaneous coronary revascularization. Design: Retrospective analysis of the Mayo Clinic PTCA Registry. Material and Methods: We examined whether the modality of treatment of diabetes mellitus (diet alone vs. oral hypoglycemics vs. insulin) impacted on the occurrence of death and death/myocardial infarction among diabetic patients after successful percutaneous coronary revascularization from January 1, 1995 through December 1998. Results: Of the 821 diabetic patients with known treatment status, 129 received diet alone, 370 oral agents, and 322 insulin. The clinical success rates of percutaneous coronary revascularization were similarly high among the groups (>90%). The adjusted risk of suffering either death or death/myocardial infarction after successful percutaneous coronary revascularization was greater for insulin-treated patients (vs. non-insulin): relative risk (95% confidence intervals) of 1.65 (0.99, 2.72) and 1.65 (1.20, 2.27), respectively. Patients treated with oral agents had lower risk of suffering death or death/myocardial infarction than insulin-treated patients (0.59 [0.36, 0.99] and 0.57 [0.38, 0.84], respectively), with a similar trend for patients on diet alone (0.96 [0.48, 1.99] and 0.65 [0.36, 1.16], respectively). Conclusions: Although the clinical success rates of PCR were similar for insulin- and non-insulin-treated diabetic patients, insulin-treated patients had worse long-term outcomes after successful percutaneous coronary revascularization.

AB - Objective: To examine whether the outcomes of diabetic patients after successful percutaneous coronary revascularization are influenced by the modality of treatment for hyperglycemia at the time of percutaneous coronary revascularization. Design: Retrospective analysis of the Mayo Clinic PTCA Registry. Material and Methods: We examined whether the modality of treatment of diabetes mellitus (diet alone vs. oral hypoglycemics vs. insulin) impacted on the occurrence of death and death/myocardial infarction among diabetic patients after successful percutaneous coronary revascularization from January 1, 1995 through December 1998. Results: Of the 821 diabetic patients with known treatment status, 129 received diet alone, 370 oral agents, and 322 insulin. The clinical success rates of percutaneous coronary revascularization were similarly high among the groups (>90%). The adjusted risk of suffering either death or death/myocardial infarction after successful percutaneous coronary revascularization was greater for insulin-treated patients (vs. non-insulin): relative risk (95% confidence intervals) of 1.65 (0.99, 2.72) and 1.65 (1.20, 2.27), respectively. Patients treated with oral agents had lower risk of suffering death or death/myocardial infarction than insulin-treated patients (0.59 [0.36, 0.99] and 0.57 [0.38, 0.84], respectively), with a similar trend for patients on diet alone (0.96 [0.48, 1.99] and 0.65 [0.36, 1.16], respectively). Conclusions: Although the clinical success rates of PCR were similar for insulin- and non-insulin-treated diabetic patients, insulin-treated patients had worse long-term outcomes after successful percutaneous coronary revascularization.

KW - Angioplasty

KW - Coronary artery disease

KW - Diabetes mellitus

KW - Diet

KW - Hypoglycemics

KW - Insulin

UR - http://www.scopus.com/inward/record.url?scp=0034906604&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034906604&partnerID=8YFLogxK

U2 - 10.1159/000048950

DO - 10.1159/000048950

M3 - Article

VL - 1

SP - 138

EP - 143

JO - HeartDrug

JF - HeartDrug

SN - 1422-9528

IS - 3

ER -